Search PubMed⌕ Search

PubMed · 3976231

[Psychological changes in multiple sclerosis].

Abstract

In dealing with our multiple sclerosis (MS) patients concomitant and consecutive symptoms of a psychical nature also deserve appropriate consideration in addition to the variety of somatic symptoms. In the following synopsis, numerous and in part divergent findings - observations, hospital statistics as well as psychodiagnostic test results - concerning the psychopathology of MS are presented. A multiplicity of mental changes, depending upon the variability of the disease process and its course, can be noticed. Over the past century euphoria was long regarded as the psychopathological trait of MS. Along with transitions in patient populations in the meantime hardly more euphoric than depressive moods are registered. Euphoric mood aberrations are to be regarded as substrate dependent disturbances, which deteriorate parallel to disease duration and severity. Intellectual dysfunctions as well as topical brain symptoms (so-called "instrumental disabilities"), obsessive laughing and crying also reflect the basic organic process. Concerning other symptoms such as depression or dysphoria, emotional lability or lack of drive, at its extreme apathy, one cannot definitely determine to what extent - in view of a multidimensional approach - these are to be regarded as mental correlates of the disease process, or as individual reactions to the disease along with considerable social consequences. Psychoses, rarely occurring in MS, can be classified either as organic, or, in seldom cases, as a fortuitous coincidence of MS and endogenous psychosis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Frank. 1985-01-31. [Psychological changes in multiple sclerosis].. https://pubmed.ncbi.nlm.nih.gov/3976231/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The Hospital Anxiety And Depression Scale.

There is a need to assess the contribution of mood disorder, especially anxiety and depression, in order to understand the experience of suffering in the setting of medical practice. Most physicians are aware of this aspect of the illness of their patients but many feel incompetent to provide the patient with reliable information. The Hospital Anxiety And Depression Scale, or HADS, was designed to provide a simple yet reliable tool for use in medical practice. The term 'hospital' in its title suggests that it is only valid in such a setting but many studies conducted throughout the world have confirmed that it is valid when used in community settings and primary care medical practice. It should be emphasised that self-assessment scales are only valid for screening purposes; definitive diagnosis must rest on the process of clinical examination.

Affective Symptoms↗

Disruption of early event-related theta synchronization of human EEG in alexithymics viewing affective pictures.

The 62-channel EEG was recorded while control non-alexithymic (n=21) and alexithymic (n=20) participants viewed sequentially presented neutral, pleasant and unpleasant pictures and subjectively rated them after each presentation. The event-related synchronization (ERS) to these stimuli was assessed in the theta-1 (4-6 Hz) and theta-2 (6-8 Hz) frequency bands. The obtained findings indicate that alexithymia influences perception of only emotional stimuli. Over anterior cortical regions alexithymia vs. control individuals in response to both pleasant and unpleasant stimuli manifested decreased left hemisphere ERS in the early test period of 0-200 ms along with enhanced ERS in response to negative vs. positive and neutral stimuli in the right hemisphere at 200-600 ms after stimulus onset. The findings provide the first EEG evidence that alexithymia construct, associated with a cognitive deficit in initial evaluation of emotion, is indexed by disrupted early frontal synchronization in the upper theta band that can be best interpreted to reflect disregulation during appraisal of emotional stimuli.

Affective Symptoms↗

Atypical antipsychotics in the treatment of schizophrenia.

Over the last few years atypical antipsychotics have been used increasingly in the pharmacological treatment of schizophrenia. This review provides an overview of the pharmacological and clinical characteristics of atypical antipsychotics. In particular we discuss their efficacy in treating psychotic and negative symptoms as well as treatment-refractory patients. The most important side effects as well as their possible interactions are reviewed in detail. Recommendations for the clinical use are given.

Affective Symptoms↗